Adrenergic nerves activate an angio-metabolic switch in prostate cancer Journal Article


Authors: Zahalka, A. H.; Arnal-Estapé, A.; Maryanovich, M.; Nakahara, F.; Cruz, C. D.; Finley, L. W. S.; Frenette, P. S.
Article Title: Adrenergic nerves activate an angio-metabolic switch in prostate cancer
Abstract: Nerves closely associate with blood vessels and help to pattern the vasculature during development. Recent work suggests that newly formed nerve fibers may regulate the tumor microenvironment, but their exact functions are unclear. Studying mouse models of prostate cancer, we show that endothelial b-adrenergic receptor signaling via adrenergic nerve-derived noradrenaline in the prostate stroma is critical for activation of an angiogenic switch that fuels exponential tumor growth. Mechanistically, this occurs through alteration of endothelial cellmetabolism. Endothelial cells typically rely on aerobic glycolysis for angiogenesis.We found that the loss of endothelial Adrb2, the gene encoding the b2-adrenergic receptor, leads to inhibition of angiogenesis through enhancement of endothelial oxidative phosphorylation. Codeletion of Adrb2 and Cox10, a gene encoding a cytochrome IVoxidase assembly factor, prevented the metabolic shift induced by Adrb2 deletion and rescued prostate cancer progression. This cross-talk between nerves and endothelial metabolism could potentially be targeted as an anticancer therapy.
Journal Title: Science
Volume: 358
Issue: 6361
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2017-10-20
Start Page: 321
End Page: 326
Language: English
DOI: 10.1126/science.aah5072
PROVIDER: scopus
PUBMED: 29051371
PMCID: PMC5783182
DOI/URL:
Notes: Article -- Export Date: 4 December 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lydia Whitney Stillman Finley
    45 Finley